CNETS is thrilled to announce the publication of a biomarker guideline and patient supplements in JAMA Oncology.

Citation: Loree JM, Chan D, Lim J, et al. Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs. JAMA Oncol. Published online October 03, 2024. doi:10.1001/jamaoncol.2024.4330

https://jamanetwork.com/journals/jamaoncology/fullarticle/2824313

A joint effort by the Commonwealth Neuroendocrine Tumour Collaboration (CommNETs), the North American Neuroendocrine Tumour Society (NANETS), the Canadian Neuroendocrine Tumour Society (CNETs) and NeuroEndocrine Cancer Australia.

jamaoncology_loree_2024_sc_240003_1727196056.92818

Supplement